TCNNF - CIK 0001754195
The table below shows Trulieve Cannabis Corp.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $272.82M | $271.48M | $201.84M | $23.10M | $12.90M | $99.64M |
| Capital expenditure | $44.19M | $122.60M | $40.24M | $164.75M | $275.90M | $99.94M |
| Investing cash flow | $13.50M | -$206.62M | -$37.47M | -$215.06M | -$215.18M | -$174.65M |
| Dividends paid | - | - | - | - | - | - |
Trulieve Cannabis Corp. reported operating cash flow of $272.82M for fiscal year 2025. That is up 0.5% from $271.48M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow grew from $19.07M (FY 2019) to $272.82M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$270.50M | -$33.44M | -$175.59M | $177.80M | $289.23M | $129.91M |